Does Dr. LUIS CRUZ RIVERA have financial conflicts of interest?

Dr. LUIS CRUZ RIVERA (MD) has received a total of $2,473 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,473 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. LUIS CRUZ RIVERA?

According to CMS Open Payments data, Dr. LUIS CRUZ RIVERA received funding from GLAXOSMITHKLINE ($380), BAYER HEALTHCARE PHARMACEUTICALS ($362), and BOSTON SCIENTIFIC CORPORATION ($268).

Does Dr. LUIS CRUZ RIVERA receive research grants or speaking fees?

Dr. LUIS CRUZ RIVERA has received $2,473 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. LUIS CRUZ RIVERA

MDReal-Time Hydrated

Specialty: Student in an Organized Health Care Education/Training Program

Practice Location: BAYAMON, PR 00956

NPI Number: 1346813862

LIFETIME INDUSTRY VALUE

$2,473

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. CRUZ RIVERA is a verified Student in an Organized Health Care Education/Training Program practitioner based in BAYAMON, PR.

Between 2021 and 2025, Dr. CRUZ RIVERA had an overall industry promotional and research financial footprint of $2,473 as recorded in the federal CMS Open Payments database.

$2,473 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. CRUZ RIVERA's primary funding source is GLAXOSMITHKLINE, which accounts for $380 (representing 15.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAXOSMITHKLINE

Rank 1

$380

15.4%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 2

$362

14.7%

BOSTON SCIENTIFIC CORPORATION

Rank 3

$268

10.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.